Cell and Gene Therapy Business Outlook

    Published: June 14, 2021 | Price: $2,200 – $30,000

    From Science and Medicine Group, the owners of the popular INSTRUMENT BUSINESS OUTLOOK, comes a new twice-a-month newsletter dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following: Market Sizing and Forecasting of CAGT Markets: Each issue sizes up the market opportunity and projects the future revenues for a given therapeutic segment. Keeping an Eye on Financing: With billions of investment dollars announced each year, Cell and Gene Therapy Business Outlook tracks who is getting financed...
    In Vitro Diagnostics Business Outlook

    Published: October 18, 2021 | Price: $2,200 – $30,000

    From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing. In Vitro Diagnostics Business Outlook offers the following: Market Sizing and Forecasting of IVD Market Segments in Every Issue Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About Industry Watch – Developments with COVID-19 and Other Testing   M&A, Distribution, Partnerships Tracked...